AstraZeneca’s AZD0901 is in Phase 3 testing in advanced gastric and GEJ cancers. Elevation Oncology’s ADC, EO-3021, is in early clinical development for advanced solid tumors, including GI ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback